Gilbert Ray Cisneros, Jr. sold Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT)
Gilbert Ray Cisneros, Jr. (D-CA), a U.S. Representative, has disclosed 10 trades in Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT) since 2019, 3 purchases and 7 sales, worth an estimated $80K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Gilbert Ray Cisneros, Jr. sold $1,001 - $15,000 of Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT) on June 19, 2020. Since that trade, CTLT is up +0.00% against the S&P 500 up +155.99%, an outperformance of -155.99%.
Across these filings, Gilbert Ray Cisneros, Jr. has been a net seller of CTLT (a buy-to-sell ratio of 0.43). The most recent disclosed CTLT transaction shown was dated September 29, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Gilbert Ray Cisneros, Jr.'s CTLT trades vs the price
CTLT is up +0.00% since Gilbert Ray Cisneros, Jr. sold on June 19, 2020, versus +155.99% for the S&P 500.
Performance since this trade
All Gilbert Ray Cisneros, Jr. CTLT trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Gilbert Ray Cisneros, Jr. & CTLT trading FAQ
Is it legal for Gilbert Ray Cisneros, Jr. to trade Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Gilbert Ray Cisneros, Jr. sell CTLT?
Gilbert Ray Cisneros, Jr. disclosed a sale of $1,001 - $15,000 of Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT) on June 19, 2020, according to public STOCK Act filings.
How has CTLT performed since Gilbert Ray Cisneros, Jr.'s trade?
Since Gilbert Ray Cisneros, Jr. sold CTLT on June 19, 2020, the stock is up +0.00%, versus +155.99% for the S&P 500 over the same period, an outperformance of -155.99%.
How many times has Gilbert Ray Cisneros, Jr. traded CTLT?
Gilbert Ray Cisneros, Jr. has disclosed 10 CTLT trades since 2019 (3 purchases and 7 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CTLT trades?
Quantellect tracks every disclosed congressional trade in Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (CTLT) on the Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings congressional trading page, which aggregates filings across all members of Congress.
Gilbert Ray Cisneros, Jr.'s CTLT tradesAll congressional filings for Catalent, Inc. (CTLT) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust HoldingsGilbert Ray Cisneros, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.